Hepatitis B: Dispelling Myths and Misconceptions
This webinar discusses common myths about hepatitis B prevention and transmission and how to address common misconceptions.
Viral Hepatitis
Back to Results
Webinar: Strategies for HCV Testing and Linkage to Care in and from Prison
This webinar explores strategies for HCV testing and linkage to care for people currently in or transitioning from prison.
Don’t Let Hepatitis C Surprise You
This fact sheet provides general information on hepatitis C for the general public.
Back to Results
HBV ECHO: Reducing Perinatal Transmission
Video developed through partnership with the Department of Health and Human Resources (HHS) Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care, Project ECHO launched HBV ECHO, a national technical assistance program that helps enhance HRSA-funded health center capacity to reduce perinatal transmission of hepatitis B. Panelists discuss the teleECHO™ curriculum, challenges in addressing perinatal HBV in the primary care setting, and patient case studies.
Back to Results
Current Methadone Access: Where are we now?
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 2: Part 2: Current Methadone Access: Where are we now?” webinar on September 24 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
Toolkit for New Viral Hepatitis Health Department Staff 2024
This toolkit is designed for new viral hepatitis health department staff to help them get oriented in their new role. It includes basic information, recommendations, key national partners, CDC funding opportunities, and where to go for help.
History of the Methadone System: How did we get here?
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
History of the Methadone System: How did we get here?
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C transmission among people who inject drugs. NCLM advocates for a more accessible and equitable methadone system that prioritizes patient health, promotes dignity, and is grounded in evidence.
Estimating hepatitis C prevalence in the United States, 2017–2020
The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of hepatitis C virus (HCV) infection in the U.S. due to inadequate representation of certain populations. Two models were developed to provide more accurate estimates of HCV prevalence among U.S. adults from 2017 to 2020.
Updated Hepatitis C Prevalence Estimates Webinar
This webinar recording features updates on new hepatitis C prevalence estimates.